
From pandemic spotlight to post-COVID crossroads: What happened to these biotech players?
Newsletter Signup - Under Article / In Page "*" indicates required fields In the heat of the COVID-19 crisis, a wave of vaccine companies stepped into the spotlight with unprecedented speed and visibility. Riding a surge of public and private …